SS
EDIT icon

Sunbelt Securities’s Editas Medicine EDIT Stock Holding History

Sunbelt Securities’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$306 Buy
124
+34
+38% +$72 ﹤0.01% 2410
2025
Q4 		$184 Hold
90
– – ﹤0.01% 2445
2025
Q3 		$312 Buy
+90
New +$251 ﹤0.01% 2340

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sunbelt Securities's EDIT Position: Q1 2026 in Review

Sunbelt Securities increased its Editas Medicine (EDIT) stake by 38% in Q1 2026, buying an estimated $72 and bringing the position to 124 shares worth $306. The position accounts for ﹤0.01% of the portfolio, ranked #2410.

Sunbelt Securities first reported a position in EDIT in Q3 2025 and has held it in 3 quarters since. The position peaked at $312 in Q3 2025. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Sunbelt Securities held 124 shares of Editas Medicine worth $306 as of Q1 2026.
  • Sunbelt Securities bought 34 Editas Medicine shares in Q1 2026, an estimated $72.
  • Editas Medicine made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2410 holding.
  • Sunbelt Securities first reported a position in Editas Medicine in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's Editas Medicine position peaked at $312 in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.